IMMX icon

Immix Biopharma

11 hedge funds and large institutions have $5.47M invested in Immix Biopharma in 2021 Q4 according to their latest regulatory filings, with 11 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

Holders
11
Holders Change
+11
Holders Change %
% of All Funds
0.17%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
11
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
M
1
Murchinson
Ontario, Canada
$2.48M 695,600 +695,600 New
LCM
2
Lynwood Capital Management
Ontario, Canada
$2.01M 565,297 +565,297 New
ACM
3
Altium Capital Management
New York
$436K 122,388 +122,388 New
UBS Group
4
UBS Group
Switzerland
$116K 32,649 +32,649 New
EVC
5
Eidelman Virant Capital
Missouri
$103K 29,856 +29,856 New
Citadel Advisors
6
Citadel Advisors
Florida
$94K 26,474 +26,474 New
Millennium Management
7
Millennium Management
New York
$73K 20,470 +20,470 New
PAM
8
PVG Asset Management
Colorado
$71.2K 20,000 +20,000 New
TSS
9
Two Sigma Securities
New York
$47K 13,173 +13,173 New
CCM
10
Context Capital Management
California
$41K 11,532 +11,532 New
CS
11
Clear Street
New York
$4K 1,000 +1,000 New
CFGS
12
Concourse Financial Group Securities
Alabama